13 results
424B3
ACST
Acasti Pharma Inc.
7 Aug 24
Prospectus supplement
4:14pm
proposal for the 2025 Annual General Meeting?
Shareholder proposals intended to be presented in proxy materials pursuant to Rule 14a-8 of the Exchange … and other requirements of the QBCA pertaining to shareholder proposals, the corporation is required to include such proposal in the information circular
424B3
ACST
Acasti Pharma Inc.
16 Oct 23
Prospectus supplement
4:31pm
to such shareholder’s compliance with the prescribed time periods and other requirements of the QBCA pertaining to shareholder proposals, the corporation
8-K
lihvyg427oq5 xm9f
29 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
424B3
0be69siviukr9vdp
15 Jul 21
Prospectus supplement
4:45pm
S-4
af4 f0rsw23viyw6
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
DEF 14A
sskh6mjyq9k78elj
9 Sep 20
Definitive proxy
4:00pm
PRE 14A
bmxt97bzw si
10 Aug 20
Preliminary proxy
12:00am
- Prev
- 1
- Next